Life Sciences Translation Services Market Size, Share and Trends Analysis, By Service Type (Clinical/Document Translation, Localization Services, Interpretation Services, Medical Writing & Editing, Transcription, and Others), By Content Type (Documents & Written Content, Digital & Online Content, and Audio & Video Content), By Application, By End-Use, and By Region, Forecast 2025-2032

Life Sciences Translation Services Market Overview and Key Insights:

The life sciences translation services market size reached USD 1,338.6 million in 2024 and is expected to register a revenue CAGR of 9.1% during the forecast period. Translation is essential for medical products to serve the worldwide population, especially people from varied backgrounds. Beyond translation, partnering with a language service provider (LSP) can benefit life sciences businesses. They have the potential to become a significant and trustworthy partner throughout the globalization process.

Market Drivers:

Growth in medical tourism and cross-border healthcare is a key driver of revenue growth in the life sciences translation services market. In recent years, the medical tourism business has grown considerably.  According to the Centre for Disease Control and Prevention (CDC), the most common operations and treatments for which people travel are dental care, cosmetic surgery, fertility treatments, cancer therapy, surgery, and organ and tissue transplantation. Many Americans fly to Mexico for medical procedures because they are significantly cheaper. For example, the typical cost of a knee replacement in the United States is USD 40,000, whereas in Mexico it is roughly USD 15,000.

Furthermore, launch of new services for life science translation is another key driver of revenue growth in the life sciences translation services market. On January 2024, Mother Tongue, an Omnicom-owned language service provider, announced that it has started expanding its offerings with the creation of Mother Tongue Life Sciences, a specialized unit that caters to pharmaceutical clients’ needs. It consists of a dedicated team of in-house project managers as well as a global network of experienced medical creatives, strategists, and linguists who speak more than 110 languages. The unit will assist clients at all stages of the project lifecycle, providing services ranging from medical translation, transcreation, and copywriting from brief to local claim research/development, regulatory submission support, and a full suite of cultural consultancy services to help clients navigate the nuances of local pharmaceutical markets.

Market Opportunity:

Rising demand for AI-powered translation and localization acts as an opportunity for the life sciences translation services market. AI’s impact on life sciences extends far beyond translation services, with applications in research, medication development, and customized treatment. Generative AI is changing translation services, allowing for accurate and context-aware translations of complicated scientific texts.

Natural Language Processing is being used to extract meaningful information from unstructured data, including as medical records and research publications, allowing for faster and more accurate diagnoses and individualized treatment programs. These AI tools not only improve translation efficiency, but they also drive research and development, tailored medicine, and general improvement in the life sciences industry.

On June 2024, RWS announced its launch of HAI, a new digital self-service platform that combines RWS’ AI-powered technology and language experience, allowing anybody to translate text quickly, conveniently, and securely – without sacrificing quality. HAI is intended to remove barriers to entering new markets by offering high-quality, professional translations online. HAI, powered by RWS’s industry-leading AI-enabled technology and backed by human expertise, offers clients a dependable one-stop shop for all their content translation needs.

Recent Trends:

Emerging trends include AI & Machine Translation (MT) with human review, growth in decentralized & global clinical trials, and personalized & patient-centric content.

Decentralization in clinical research is a novel technique with numerous advantages. Decentralized Clinical Trials (DCTs) have increasing reliance on digital health technologies, making software localization critical for effective communication and data collecting. This covers things like units of measurement, addresses, numbers, time and date formats, holidays, and societal norms.

Moving to virtual clinical trials raises concerns about patient privacy. Concerns about patient validation cause conflict with patients’ privacy concerns and readiness to disclose confidential information electronically. However, there are solutions available to improve security while protecting patient privacy, such as role-based access to electronic investigator site data.

Restraints & Challenges:

Risk of translation errors leading to regulatory rejections are key limiting factors for growth of the market. The FDA and EU authorities require professional translation of all patient-facing materials into a language the participant understands. Since some EU countries have multiple official languages, organizations must account for language variations such as American and British English. For example, when translating a document into French for use in France, they must adapt it for French-speaking participants in Belgium, Switzerland, and Canada.

Localization also addresses issues such as how content is displayed on a screen. For instance, not all languages read from left to right, so design adjustments may be required. Significant text expansion can be expected in some languages, such as when translating from English into German.

Service Type Segment Insights and Analysis:

Based on the service type, life sciences translation services market is segmented into clinical/document translation, localization services, interpretation services, medical writing & editing, transcription, and others.

Clinical/document translation segment contributed the largest market revenue share in 2024. In the United States, the FDA requires that the source of any translation accompany foreign language counterparts. This translation must include the translator’s name, address, and a summary of their qualifications. In addition, translations of literature or other works must include copies of the source publications. 

On November 2023, TransPerfect Life Sciences, a leading provider of services and solutions to support worldwide clinical trials and product development in the biopharmaceutical industry, has released version 10.5 of its award-winning Trial Interactive eClinical platform. This new edition is a substantial improvement that provides new benefits to sponsors by allowing them to automate oversight for proactive and predictive trial management.

Medical writing & editing segment contributed the highest market growth rate in 2024. The life sciences market is rapidly developing and is expected to continue doing so. Medical writers collaborate closely with scientists, clinicians, and other groups in the medical and biotechnology fields to curate a wide range of content, including patient information sheets, medical reports, clinical research reports, and regulatory submissions.

On August 2023, Vital, a leading artificial intelligence (AI)-driven digital health startup, has announced the release of its AI-powered Doctor-to-Patient Translator, which is intended to translate highly sophisticated medical terminology into plain language that any patient can comprehend. Vital’s HIPAA-compliant Doctor-to-Patient Translator uses cutting-edge Large Language Models (LLMs) and Natural Language Processing (NLP) to produce 5th-grade reading-level explanations of lab and imaging results, doctor notes, discharge summaries, patient instructions, and other critical medical information.

Application Segment Insights and Analysis:

Based on the application, the life sciences translation services market is segmented into clinical trials & research, regulatory compliance & submissions, medical devices & healthcare products, marketing & commercialization, and others.

Medical devices & healthcare products segment contributed the largest market revenue share and highest growth rate in 2024. Medical equipment must be translated for users in various languages to minimize disinformation and maintain regulatory compliance. With the medical business becoming more globalised, accurate medical device translation services assist manufacturers in meeting regulatory standards while ensuring that healthcare professionals and end users completely comprehend the device’s functionality.

On February 2024, Milestone Localization, a major global provider of translation and localization services, has launched a new business, Milestone Localization Life Sciences. This specialist section is focused on serving the translation and localization needs of the life sciences business, which includes healthcare, medical equipment, and pharmaceuticals. Milestone Localization has honed its ability to deliver expert translation services tailored to meet the specific language requirements of the Life sciences industry.

End-Use Segment Insights and Analysis:

Based on the end-use, the life sciences translation services market is segmented into pharmaceutical & biotechnology companies, medical device manufacturers, Contract Research Organizations (CROs), regulatory agencies & health authorities, hospitals & healthcare providers, and others.

Pharmaceutical & biotechnology companies segment contributed the largest market revenue share in 2024. Pharmaceutical businesses modify and localize material to satisfy the cultural and linguistic needs of their varied audiences, while adhering to legal and ethical standards. Companies can use these services to efficiently communicate during regulatory filings and clearances, making them an essential tool for operating in the global marketplace.

On April 2024, Voyce, a prominent provider of real-time medical interpretation services, and Hamilton Health Sciences (HHS) announced a successful collaboration to improve communication for patients who do not understand English. OBIO’s Life Sciences Critical Technologies & Commercialization (LSCTC) Center of Excellence supported Voyce’s adoption following a successful evaluation through the Early Adopter Health Network (EAHN) initiative. These interpretation services ensure that every patient, regardless of native language, receives the attention and understanding they need.

Medical device manufacturers segment is expected to have the highest growth rate throughout the forecasted period. Medical device translation services are critical in the healthcare sector. Communication is essential for ensuring patient safety and meeting regulatory requirements. Important documentation, including as user manuals, labels, packaging, instructions, and clinical trial papers, must be translated precisely and accurately.

On May 2024, Pal International, a global pioneer in infection control products, and Mastermind Translations, a specialised translation service provider for life science industries, have established a strategic alliance to strengthen Pal International’s position in over 50 international markets. Originating from Pal International’s request to translate regulatory material, Mastermind Translations offered not only translations but also essential recommendations to guarantee compliance with the most recent EU rules for Class IIa medical devices.

Geographical Outlook:

Life sciences translation services market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamic. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different region and countries.

North America Life Sciences Translation Services Market:

North America is registered to have highest market share in life sciences translation services market in 2024, driven by rising demand for AI-powered translation and localization. On October 2024, MasterControl, a major provider of manufacturing and quality management software solutions for regulated sectors, revealed Document Translator’s public availability during the Masters Summit. The new AI-powered solution enables life science manufacturers to swiftly translate important procedural documents into a range of languages, ensuring global compliance while protecting data and lowering translation costs. This enables them to better assure worldwide compliance while adhering to their strict manufacturing timetables.

Asia Pacific Life Sciences Translation Services Market:

Asia Pacific is experiencing the fastest growth rate during the forecasted period. The region’s status as a major hub for medical tourism and cross-border healthcare is expected to drive market expansion. Advanced medical facilities, skilled healthcare personnel, and cost-effective treatment alternatives are propelling this robust growth trajectory, enhancing Asia Pacific’s appeal as a medical tourism destination. Countries like Malaysia, Thailand, Japan, India, and Singapore are developing as specific leaders in this arena, providing worldwide visitors with high-quality and innovative healthcare.

On August 2022, TransPerfect, the world’s largest provider of language and technology solutions for worldwide business, has announced the establishment of a new office in Noida, India, as part of the Delhi National Capital Region. TransPerfect Delhi, the company’s third office in India and the latest addition to its global network of facilities, serves as a regional hub and document review center for TransPerfect Legal Solutions (TLS). 

Competition Analysis:

The life sciences translation services market is characterized by a fragmented structure, with several players competing across various segments and regions. List of major players included in the life sciences translation services market report are:

• Vistatec
• Lionbridge Technologies, LLC
• Language Scientific Inc
• Morningside, Inc
• Seprotec
• TransPerfect Life Sciences
• Milestone Localization Private Limited
• Propio Language Services
• Stepes
• Janus Worldwide
• Argos Multilingual
• Welocalize Life Sciences
• ALM Translations Ltd
• BURG Translations
• Crimson Interactive Inc.

Strategic Developments in Life Sciences Translation Services Market:

• In August 2024, RxTran, a part of Language Scientific, has launched a new project on behalf of the Limited English Proficiency (LEP) population. The US Census Bureau has previously reported that people in the United States speak more than 350 languages, with roughly one in every five speaking a language other than English in their homes.The vast majority of these LEP people live in low-income, low-education households.
• In January 2024, RWS has announced the release of Evolve, a pioneering linguistic AI solution that provides considerable efficiency improvements for worldwide organizations with high translation demands. Evolve is a significant step forward for the translation industry by combining human and artificial intelligence, transforming translation procedures and the time required to get high-quality outcomes.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights Of Life Sciences Translation Services Market Report:

The Life Sciences Translation Services market report offers a detailed analysis of market size, including historical revenue (in USD Million) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Service Type Outlook (Revenue, USD Million; 2022-2032)
  • Clinical/Document Translation
  • Localization Services
  • Interpretation Services
  • Medical Writing & Editing
  • Transcription
  • Others

• Content Type Outlook (Revenue, USD Million; 2022-2032)
  • Documents & Written Content
  • Digital & Online Content
  • Audio & Video Content

• Application Outlook (Revenue, USD Million; 2022-2032)
  • Clinical Trials & Research
  • Regulatory Compliance & Submissions
  • Medical Devices & Healthcare Products
  • Marketing & Commercialization
  • Others

• End-Use Outlook (Revenue, USD Million; 2022-2032)
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Research Organizations (CROs)
  • Regulatory Agencies & Health Authorities
  • Hospitals & Healthcare Providers
  • Others

• Regional Outlook (Revenue, USD Million; 2022-2032)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Benelux
    • Nordic Countries
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Oceania
    • ASEAN Countries
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Frequently Asked Questions (FAQ) about the Life Sciences Translation Services market report